PQP-15950-67028
4 vaccinations
5 coded responses
35 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 775 / TX
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
255-21110-62525
Child or adolescent in my care · Male · 2022-07-19
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Pfizer-BioNTech
- 2020-12-31
- 2021-01-01
-
2021-01-03
Survey response — days 1–6 daily, dose 1MedDRA: Back pain — Feeling: Good · Muscle or body achesFree text: Lower back painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-04
Survey response — days 1–6 daily, dose 1MedDRA: Back pain, Muscle tightness, Rash — Feeling: Good · Muscle or body aches, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Possible facial rash, lower back pain, and tight musclesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-04
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-05
Survey response — days 1–6 daily, dose 1MedDRA: Localised infection — Feeling: GoodFree text: Toenail infection unsure if relatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Survey response — day 7, dose 1MedDRA: Nail bed infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Infection at base of toenail, likely unrelatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Report sent to call center — day 7, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-14
-
2021-01-22
Dose 2 — Pfizer-BioNTech
- 2021-01-22
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-02-05
- 2021-02-10
- 2021-02-12
- 2021-02-21
- 2021-02-28
- 2021-03-05
- 2021-07-23
-
2021-10-08
Dose 3 — Pfizer-BioNTech
- 2022-01-22
-
2022-06-14
Dose 4 — Pfizer-BioNTech
- 2022-06-14
-
2022-06-16
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend schoolAdult check-in
- 2022-06-17
- 2022-06-18
-
2022-06-19
Health check-in — days 1–6 daily, dose 4Feeling: Good · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-06-20
Survey response — days 1–6 daily, dose 4MedDRA: COVID-19 — Feeling: FairFree text: Likely covid positiveMedDRA releases: 2024-11 · check-in free text available
- 2022-06-21
- 2022-06-28
- 2022-07-07
- 2022-07-12
- 2022-07-19
- 2022-07-26
- 2022-12-13
- 2023-06-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Pfizer-BioNTech | |
| 2 | 2021-01-22 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
| 4 | 2022-06-14 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Lower back pain
Systemic reaction (other): Possible facial rash, lower back pain, and tight muscles
Systemic reaction (other): Toenail infection unsure if related
Release 1 — day 7, dose 1
Systemic reaction (other): Infection at base of toenail, likely unrelated
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Likely covid positive
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Back pain | ✓ | ✓ | ✓ |
| SRO | COVID-19 | · | · | ✓ |
| SRO | Localised infection | ✓ | ✓ | ✓ |
| SRO | Muscle tightness | ✓ | ✓ | ✓ |
| SRO | Nail bed infection | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release